Department of Internal Medicine (DIMI), University of Genoa, Genoa, Italy.
Unit of Clinical Immunology and Translational Medicine, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
J Clin Immunol. 2024 Jun 7;44(6):142. doi: 10.1007/s10875-024-01744-3.
Common Variable Immunodeficiency (CVID) is characterized by hypogammaglobulinemia and failure of specific antibody production due to B-cell defects. However, studies have documented various T-cell abnormalities, potentially linked to viral complications. The frequency of Cytomegalovirus (CMV) replication in CVID cohorts is poorly studied. To address this gap in knowledge, we set up an observational study with the objectives of identifying CVID patients with active viraemia (CMV, Epstein-Barr virus (EBV)), evaluating potential correlations with immunophenotypic characteristics, clinical outcome, and the dynamic progression of clinical phenotypes over time.
31 CVID patients were retrospectively analysed according to viraemia, clinical and immunologic characteristics. 21 patients with non CVID humoral immunodeficiency were also evaluated as control.
Active viral replication of CMV and/or EBV was observed in 25% of all patients. CMV replication was detected only in CVID patients (16%). CVID patients with active viral replication showed reduced HLA-DR NK counts when compared with CMV-DNA negative CVID patients. Viraemic patients had lower counts of LINDNAM and LINCD16 inflammatory lymphoid precursors which correlated with NK-cell subsets. Analysis of the dynamic progression of CVID clinical phenotypes over time, showed that the initial infectious phenotype progressed to complicated phenotypes with time. All CMV viraemic patients had complicated disease.
Taken together, an impaired production of inflammatory precursors and NK activation is present in CVID patients with active viraemia. Since "Complicated" CVID occurs as a function of disease duration, there is need for an accurate evaluation of this aspect to improve classification and clinical management of CVID patients.
常见变异性免疫缺陷症(CVID)的特征是低丙种球蛋白血症和由于 B 细胞缺陷导致的特异性抗体产生失败。然而,研究已经记录了各种 T 细胞异常,这些异常可能与病毒并发症有关。CVID 队列中巨细胞病毒(CMV)复制的频率研究得还不够。为了填补这一知识空白,我们进行了一项观察性研究,目的是确定患有活动性病毒血症(CMV、EBV)的 CVID 患者,评估与免疫表型特征、临床结果以及随时间推移的临床表型动态进展的潜在相关性。
根据病毒血症、临床和免疫特征对 31 例 CVID 患者进行回顾性分析。还评估了 21 例非 CVID 体液免疫缺陷患者作为对照。
所有患者中有 25%观察到 CMV 和/或 EBV 的活跃病毒复制。CMV 复制仅在 CVID 患者中检测到(16%)。与 CMV-DNA 阴性的 CVID 患者相比,患有活动性病毒复制的 CVID 患者 HLA-DR-NK 计数减少。病毒血症患者的 LINDNAM 和 LINCD16 炎症淋巴前体细胞计数较低,与 NK 细胞亚群相关。对 CVID 临床表型随时间动态进展的分析表明,初始感染性表型随时间进展为复杂表型。所有 CMV 病毒血症患者均患有复杂疾病。
总之,在患有活动性病毒血症的 CVID 患者中,存在炎症前体产生受损和 NK 激活。由于“复杂”CVID 是疾病持续时间的函数,因此需要对这一方面进行准确评估,以改善 CVID 患者的分类和临床管理。